FOR RESEARCH PURPOSES ONLY • 21+ ACCESS
PRIMARY CATALOGWholesale Kits · 10 vials eachShop kits →

IMMUNE / DIRECT CATALOG PRICING

LL-37

LL-37 is the 37-amino-acid, carboxyl-terminal host-defense peptide released from the human cathelicidin precursor hCAP18.

Format
Lyophilized research vial
Listed formats
1
Available now
1
Catalog class
Immune

Choose a listed format

Pricing, availability, quantity tiers, and member eligibility are checked again when an order is submitted.

TECHNICAL OVERVIEW

Identity first, claims kept in scope.

LL-37 is the 37-amino-acid, carboxyl-terminal host-defense peptide released from the human cathelicidin precursor hCAP18.

The immune classification supports catalog navigation; it does not establish efficacy, safety, approval, human use, or equivalence to a material used in a cited study.

SPECIFICATIONS

Material class
Immune
Physical format
Lyophilized vial
Research status
Research purposes only
Commerce status
1 format currently orderable

PLAIN-LANGUAGE RESEARCH SNAPSHOT

What researchers have actually studied.

LL-37 is the 37-amino-acid, carboxyl-terminal host-defense peptide released from the human cathelicidin precursor hCAP18.

Research covered
Researchers characterized LL-37 processing in human neutrophils and tested its membrane interactions and antimicrobial, chemotactic, and cytotoxic properties in vitro.
Important limit
The cited studies are mechanistic and in vitro and do not establish clinical outcomes or verify equivalence of a separately supplied synthetic vial.
Catalog availability does not imply evidence strength, product equivalence, safety, efficacy, or a suggested combination. No dosage or use recommendation is provided.

FACTUAL FAQ

LL-37 catalog questions

What formats are currently listed?

5 mg. Current price and stock state appear above.

What did researchers study?

Researchers characterized LL-37 processing in human neutrophils and tested its membrane interactions and antimicrobial, chemotactic, and cytotoxic properties in vitro.

What is the most important evidence limit?

The cited studies are mechanistic and in vitro and do not establish clinical outcomes or verify equivalence of a separately supplied synthetic vial.

How should this listing be interpreted?

It is a research-material catalog listing, not medical guidance, a dosage recommendation, a safety or efficacy claim, or evidence of regulatory approval.

Where can I review related scientific references?

Use the PSC research library to locate general and compound-related source material. Open related research references →

DIRECT CATALOG SUPPORT

Looking for something specific?

Contact PSC before ordering when you need help locating a research compound, confirming current stock or product identity, understanding Bitcoin checkout, or requesting bulk pricing.

One support address. Include the exact catalog name and desired quantity for the fastest response.

Email catalog support↗